Congratulations to Prof. Paul Barlow and Dr Andy Herbert who are scientific co-founders of Gemini Therapeutics, a new medical therapeutics company that is developing treatments for a common cause of blindness - age-related macular degeneration. The company has just announced $42.5 million of venture capital investment.
Gemini Therapeutics Founded
New medical company secures big investment
Thursday, October 19, 2017